News
![ImageJ=1.45b
unit=um](https://pharmaphorum.com/wp-content/uploads/2022/09/calibr_abbvie_sqitchable_CAR-T_cells.jpg)
First human data backs Calibr/AbbVie's "switchable" CAR-T th...
California biotech Calibr and partner AbbVie have reported the first clinical data on a new CAR-T technology, which uses "switchable" cells that aim to eliminate the life-threatening side-e